CIBC Private Wealth Group
TXG icon

CIBC Private Wealth Group’s 10x Genomics TXG Stock Holding History

CIBC Private Wealth Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$359 Hold
22
– – ﹤0.01% 3106
2025
Q3 		$257 Hold
22
– – ﹤0.01% 2930
2025
Q2 		$255 Sell
22
-540
-96% -$4.92K ﹤0.01% 2890
2025
Q1 		$4.01K Buy
562
+545
+3,206% +$6.87K ﹤0.01% 2514
2024
Q4 		$269 Hold
17
– – ﹤0.01% 2879
2024
Q3 		$384 Hold
17
– – ﹤0.01% 2996
2024
Q2 		$314 Hold
17
– – ﹤0.01% 3017
2024
Q1 		$630 Buy
+17
New +$747 ﹤0.01% 2912

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's TXG Position: Q4 2025 in Review

CIBC Private Wealth Group held its 10x Genomics (TXG) position steady in Q4 2025 at 22 shares worth $359. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

CIBC Private Wealth Group first reported a position in TXG in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.01K in Q1 2025. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • CIBC Private Wealth Group held 22 shares of 10x Genomics worth $359 as of Q4 2025.
  • CIBC Private Wealth Group left its 10x Genomics share count unchanged in Q4 2025.
  • 10x Genomics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3106 holding.
  • CIBC Private Wealth Group first reported a position in 10x Genomics in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's 10x Genomics position peaked at $4.01K in Q1 2025.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.